045: Molecular determinants of therapy response in metastatic clear cell renal cell cancer

HIPO Investigator:

Prof. Sascha Pahernik

Prof. Holger Sültmann

Prof. Markus Hohenfellner

Prof. Wilfried Roth

Prof. Stefan Fröhling

Prof. Stefan Duensing

Entity: ccRCC


Dieffenbacher S et al.; Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL; Future Sci OA 2018

Dietz S et al.; Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy; Oncotarget 2017


DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.